HRT Financial’s Firefly Neuroscience AIFF Stock Holding History

HRT Financial’s Portfolio AIFF Stock Details AIFF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-435	Closed	-$4K	–	3233
2023 Q2	$4K	Buy	+435	New	+$4.93K	﹤0.01%	2246

Other funds holding AIFF

Lafayette Investments Ashton, Maryland $494M AUM 11.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Moors & Cabot Boston, Massachusetts $2.34B AUM 30.42% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

HRT Financial's AIFF Position: Q3 2023 in Review

HRT Financial sold out of Firefly Neuroscience (AIFF) in Q3 2023, closing a stake of 435 shares — an estimated $4K sold.

HRT Financial first reported a position in AIFF in Q2 2023 and held it in 1 quarter. The position peaked at $4K in Q2 2023. 12 funds tracked by Wall St. Rank hold AIFF as of Q3 2023.

HRT Financial reported no remaining Firefly Neuroscience position as of Q3 2023 after selling out during the quarter.
HRT Financial sold 435 Firefly Neuroscience shares in Q3 2023, an estimated $4K.
HRT Financial first reported a position in Firefly Neuroscience in Q2 2023 and held it in 1 quarter.
HRT Financial's Firefly Neuroscience position peaked at $4K in Q2 2023.
12 funds tracked by Wall St. Rank held Firefly Neuroscience as of Q3 2023.

Based on HRT Financial's 13F filing for Q3 2023, filed 13 Nov 2023.